CLDX Latest Headlines

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Owlet (OWLT), Celldex (CLDX) and Edgewise Therapeutics (EWTX)

at www.tipranks.com (Wed, 23-Sep 7:50 AM)

Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Adicet Bio (ACET) and Amgen (AMGN)

at www.tipranks.com (Wed, 23-Sep 7:20 AM)

Canaccord Genuity Sticks to Their Buy Rating for Celldex (CLDX)

at www.tipranks.com (Wed, 23-Sep 7:16 AM)

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Celldex (CLDX) and Inventiva (IVA)

at www.tipranks.com (Wed, 23-Sep 6:50 AM)

Wells Fargo Keeps Their Buy Rating on Celldex (CLDX)

at www.tipranks.com (Wed, 23-Sep 6:45 AM)

Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Celldex (CLDX) and Vertex Pharmaceuticals (VRTX)

at www.tipranks.com (Wed, 23-Sep 6:40 AM)

Barclays Sticks to Their Buy Rating for Celldex (CLDX)

at www.tipranks.com (Wed, 23-Sep 5:05 AM)

Celldex Highlights Phase 3 Barzolvolimab Data With Complete Response Near 54% at 24 Weeks in CSU

Market Chameleon (Tue, 22-Sep 11:36 AM)

Celldex reports Phase 3 barzolvolimab CSU wins as complete response rates approach 54% by Week 24

Market Chameleon (Tue, 22-Sep 7:28 AM)

Celldex falls after late-stage trial data for hives therapy

at seekingalpha.com (Tue, 22-Sep 8:36 AM)

Celldex reports strong Phase 3 data in urticaria

at www.tipranks.com (Tue, 22-Sep 7:28 AM)

Barzolvolimab’s Strong CSU Prospects Lead Sam Slutsky to Reaffirm Buy on CLDX with Unchanged $56 Price Target

at www.tipranks.com (Sun, 20-Sep 12:05 PM)